Internal Medicine · Morgantown, WV
NPI
1801381967
Since 2018
Specialty
Internal Medicine
Code 207R00000X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
1 Medical Center Dr
Morgantown, WV, 26506
Phone (855) 988-2273
Groups this clinician bills Medicare through
Medicare paid, 2024
$21K
372 services
Medicare patients, 2024
162
Average age 70
Drug cost, 2024
$2.8M
771 prescriptions
Company payments, 2025
$563
From 9 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Maryam Tetlay was code 99214 (office e&m - established), 141 times for 100 patients. In total Maryam Tetlay billed 372 services in 18 codes, and Medicare paid $21K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2023-09-01.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 141 | 100 | $67.95 | $9,580 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 72 | 63 | $11.91 | $858 |
| 99232 Hospital E&M - Subsequent | Facility | 50 | 18 | $59.62 | $2,981 |
| 99204 Office E&M - New | Office | 32 | 32 | $95.44 | $3,054 |
| 95251 Test - Miscellaneous | Office | 31 | 21 | $23.35 | $724 |
By year: 2023 $5,054 for 70 services; 2024 $21K for 372 services.
Medicare prescription drug claims, 2024
In 2024, the drug Maryam Tetlay prescribed most often to Medicare patients was Levothyroxine Sodium, with 106 prescriptions and refills. In total Maryam Tetlay wrote 771 Medicare prescriptions that cost $2.8M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Levothyroxine Sodium Generic | 106 | 288 | 40 | $1,032 |
| Mounjaro Tirzepatide | 75 | 97 | 16 | $100K |
| Methimazole Generic | 49 | 121 | 16 | $466 |
| Jardiance Empagliflozin | 38 | 80 | 12 | $46K |
| Ozempic Semaglutide | 36 | 55 | 16 | $48K |
| Lantus Solostar Insulin Glargine,hum.Rec.Anlog | 34 | 75 | 14 | $4,172 |
| Trulicity Dulaglutide | 34 | 41 | Under 11 | $39K |
| Metformin Hcl Er Metformin Hcl | 33 | 72 | Under 11 | $371 |
| Pioglitazone Hcl Generic | 21 | 41 | Under 11 | $232 |
| Nano 2nd Gen Pen Needle Pen Needle, Diabetic | 19 | 41 | Under 11 | $1,930 |
| Testosterone Cypionate Generic | 18 | 26 | 11 | $897 |
| Ultra-Fine Nano Pen Needle Pen Needle, Diabetic | 18 | 22 | Under 11 | $1,217 |
| Metformin Hcl Generic | 16 | 48 | Under 11 | $120 |
| Insulin Lispro Kwikpen U-100 Insulin Lispro | 15 | 40 | Under 11 | $6,179 |
| Hydrocortisone Generic | 13 | 30 | Under 11 | $531 |
Brand drugs: 373 claims; generic drugs: 354 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Maryam Tetlay $563 ($563 in general payments such as food, travel and fees) from 9 companies. The largest payer was Novo Nordisk Inc with $215.
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc NVO | 16 | $215 |
| Insulet Corporation PODD | 3 | $190 |
| Ascendis Pharma Endocrinology Inc ASND | 1 | $26.5 |
| Antares Pharma, Inc. | 1 | $25.92 |
| Neurocrine BioSciences, Inc. NBIX | 1 | $25.31 |
| Abbott Laboratories ABT | 1 | $25.22 |
| Xeris Pharmaceuticals, Inc. | 1 | $24.99 |
| Kyowa Kirin, Inc. 4151.T | 1 | $18 |
| Beta Bionics, Inc. BBNX | 1 | $12.82 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.